UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)

128 filings reported holding URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share as of Q1 2024.
UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 27.2M shares of 46.2M outstanding shares and own 58.74% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (3.26M shares), RA CAPITAL MANAGEMENT, L.P. (3.08M shares), GREAT POINT PARTNERS LLC (2.62M shares), MENORA MIVTACHIM HOLDINGS LTD. (2.3M shares), BlackRock Inc. (1.72M shares), COWEN AND COMPANY, LLC (1.63M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.3M shares), CREDIT SUISSE AG/ (1.2M shares), Point72 Asset Management, L.P. (1.11M shares), and Jefferies Financial Group Inc. (840K shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.